Current Neuropharmacology
Title:INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker
Volume: 15 Issue: 3
Author(s): Hagop S. Akiskal
Affiliation:
Export Options
About this article
Cite this article as:
Akiskal S. Hagop, INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker, Current Neuropharmacology 2017; 15 (3) . https://dx.doi.org/10.2174/1570159X14666161021100046
DOI https://dx.doi.org/10.2174/1570159X14666161021100046 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
24
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Beta-adrenergic Signaling in the Development and Progression of Pulmonary and Pancreatic Adenocarcinoma
Current Cancer Therapy Reviews Chemopreventive Agents Alters Global Gene Expression Pattern: Predicting their Mode of Action and Targets
Current Cancer Drug Targets NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO
Current Drug Targets Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients
Current Drug Safety Dietary Intake and Bone Status with Aging
Current Pharmaceutical Design Other Activities
Current Bioactive Compounds The Vectorcardiogram and the Main Dromotropic Disturbances
Current Cardiology Reviews Retraction Notice: Emerging Targets for COPD Therapy
Current Drug Targets - Inflammation & Allergy Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Neuron-Microglia Interaction in Neuroinflammation
Current Protein & Peptide Science Influence of ESR1 Variants on Clinical Characteristics and Fibromyalgia Syndrome in Turkish Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Pathophysiological Implications of Dipeptidyl Peptidases
Current Protein & Peptide Science Turning Up the Pressure on Vascular Disease
Current Neurovascular Research Adolescent Risk Pathways Toward Schizophrenia: Sustained Attention and the Brain
Current Topics in Medicinal Chemistry A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Pre-attentive Visual Processing in Alzheimer’s Disease: An Event-related Potential Study
Current Alzheimer Research Editorial [Hot Topic: New Avenues of Research on Multiple Sclerosis from the Perspective of Chronic Cerebrospinal Venous Insufficiency Paradigm (Guest Editor: Marian Simka)]
Reviews on Recent Clinical Trials